Work

RE: Dietary interventions in cancer: a systematic review of all randomized controlled trials

Year: 2024
Type: letter
Abstract: We applaud Ilerhunmwuwa and colleagues (1) for undertaking this much needed meta-analysis to demonstrate the breadth and depth of studies that have been performed using nutritional interventions in oncology patients. One of the most revealing elements of this study is that the majority of the 252 studies conducted between 1997 and 2023 have assessed primary endpoints that show feasibility, adherence to diet, weight and body composition, or translational endpoints rather than primary endpoints related to dietary interventions and cancer outcomes (1). This article shows that few clinical trials have been conducted that measure the impact of cancer outcomes using dietary changes. Only 20 trials had a primary endpoint designed to detect an improvement in cancer outcomes, and of those, only 8 met their primary endpoint. However, more than half of the studies that met their endpoint lacked power calculations, and the remainder failed to meet their enrollment criteria. Of the 12 that did not meet their cancer endpoints, most had power calculations but did not accrue the number of patients needed to detect a difference in the endpoint. Therefore, each of these studies showed flaws. Unfortunately, this review did not account for behavioral factors or engagement levels of the interventions associated with the cancer endpoints studied. Inclusion of those factors would have shown the potential influence they had on intervention and effectiveness of outcomes. Nor did this review assess the risk of bias, which, along with the factors already discussed, clearly does not support the statement that there is “limited evidence to support dietary interventions as a therapeutic tool in cancer care (1)” but conversely demonstrates the necessity for more rigorous research in that area. In fact, it is well established that obesity is associated with poor cancer outcomes (2,3) and that maintaining weight or losing weight is associated with decreases in cancer recurrence and improvement in overall survival, as shown in innumerable studies, in particular for breast and prostate cancer patients (4-6). This suggests that dietary intervention trials, if powered appropriately and if they accrue their goals, should lead to improved cancer outcomes, because they have already been proven successful for weight control in cancer patients. Taking all factors into account, the true value of this study demonstrates the importance of utilizing its findings as evidence to shift focus from feasibility and weight loss toward investigating direct impacts on cancer outcomes. Often grant applications that are designed with the intent to evaluate the ability for dietary interventions to improve cancer outcomes as a primary endpoint are rejected, on the basis of the need for pilot studies to first demonstrate feasibility. This meta-analysis should serve as the evidence that demonstrates feasibility so that useful progress can be made in assessing what the impact of dietary change can have on improving cancer treatment. No new data were generated or analyzed for this correspondence. Kuang-Yi Wen, PhD (Writing—review & editing), Sara E. Burke, MPH (Formal analysis; Writing—review & editing), Jenna L. Jacoby, MS (Data curation, Writing—review & editing), Jessica Liang, BS (Writing—review & editing), and Nicole L. Simone, MD (Conceptualization, Writing—original draft). This work was supported by the National Institutes of Health NIH/NCI R01CA227479 to NLS and the American Institute of Cancer Research to KYW and NLS. The authors have no conflicts to disclose. The NCI R01 funding for NLS to interpret the data presented and this grant and the AICR grant from KYW and NLS led to the decision to submit this manuscript. The authors would like to thank Joan W. Blumberg and Robin W. Wells for their edits of this correspondence.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W4399759818
Cites: 7
Cited by: 1
Related to: 10